Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank L Heppner

Showing results (1-10 of 174) with videos related to

Pageof 18
Sort By:
Current Opinion in Immunology|September 3, 2004
Recent developments in prion immunotherapyFrank L Heppner, Adriano Aguzzi
The Lancet. Neurology|July 22, 2005
Alzheimer's amyloid immunotherapy: quo vadis?Sam Gandy, Frank L Heppner
Neuron|July 11, 2008
Cerebral and peripheral amyloid phagocytes--an old liaison with a new twistMathias Jucker, Frank L Heppner
Plos Medicine|December 21, 2005
Breaking up (amyloid) is hard to doSam Gandy, Frank L Heppner
Neuron|May 31, 2013
Microglia as dynamic and essential components of the amyloid hypothesisSam Gandy, Frank L Heppner
Seminars in Immunopathology|October 6, 2009
Modeling multiple sclerosis in laboratory animalsBettina Schreiner, Frank L Heppner, Burkhard Becher
Biological Chemistry|October 1, 2003
No superoxide dismutase activity of cellular prion protein in vivoGregor Hutter, Frank L Heppner, Adriano Aguzzi
Alzheimer Disease and Associated Disorders|June 16, 2004
Current concepts and future prospects for Alzheimer disease vaccinesFrank L Heppner, Sam Gandy, JoAnne McLaurin
Nature Reviews. Neuroscience|May 21, 2015
Immune attack: the role of inflammation in Alzheimer diseaseFrank L Heppner, Richard M Ransohoff, Burkhard Becher
Glia|January 26, 2011
Microglia/macrophages promote glioma progressionHaiyan Zhai, Frank L Heppner, Stella E Tsirka
Pageof 18

Showing results (1-10 of 174) with videos related to

Sort By:
Pageof 18
Current Opinion in Immunology|September 3, 2004
Recent developments in prion immunotherapyFrank L Heppner, Adriano Aguzzi
The Lancet. Neurology|July 22, 2005
Alzheimer's amyloid immunotherapy: quo vadis?Sam Gandy, Frank L Heppner
Neuron|July 11, 2008
Cerebral and peripheral amyloid phagocytes--an old liaison with a new twistMathias Jucker, Frank L Heppner
Plos Medicine|December 21, 2005
Breaking up (amyloid) is hard to doSam Gandy, Frank L Heppner
Neuron|May 31, 2013
Microglia as dynamic and essential components of the amyloid hypothesisSam Gandy, Frank L Heppner
Seminars in Immunopathology|October 6, 2009
Modeling multiple sclerosis in laboratory animalsBettina Schreiner, Frank L Heppner, Burkhard Becher
Biological Chemistry|October 1, 2003
No superoxide dismutase activity of cellular prion protein in vivoGregor Hutter, Frank L Heppner, Adriano Aguzzi
Alzheimer Disease and Associated Disorders|June 16, 2004
Current concepts and future prospects for Alzheimer disease vaccinesFrank L Heppner, Sam Gandy, JoAnne McLaurin
Nature Reviews. Neuroscience|May 21, 2015
Immune attack: the role of inflammation in Alzheimer diseaseFrank L Heppner, Richard M Ransohoff, Burkhard Becher
Glia|January 26, 2011
Microglia/macrophages promote glioma progressionHaiyan Zhai, Frank L Heppner, Stella E Tsirka
Pageof 18